EX VIVO PRESERVATION FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: MAKING TOLERANCE INDUCTION PROTOCOLS CLINICALLY APPLICABLE
$1,385,292FY2025Defense Health AgencyDOD
The General Hospital Corporation
Investigators
View source on USAspending →EX VIVO PRESERVATION FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: MAKING TOLERANCE INDUCTION PROTOCOLS CLINICALLY APPLICABLE · GrantIndex